Danaher Corp. (DHR) News
Filter DHR News Items
DHR News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
DHR News Highlights
- For DHR, its 30 day story count is now at 17.
- Over the past 22 days, the trend for DHR's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- TOP, RNA and CDXS are the most mentioned tickers in articles about DHR.
Latest DHR News From Around the Web
Below are the latest news stories about DANAHER CORP that investors may wish to consider to help them evaluate DHR as an investment opportunity.
Danaher (DHR) Beats Stock Market Upswing: What Investors Need to KnowDanaher (DHR) closed the most recent trading day at $232.86, moving +0.63% from the previous trading session. |
Top 3 Healthcare Stock Picks for the New YearBuy these healthcare stocks for 2024 trading at bargain prices before their earnings inflect higher on improving fundamentals. |
Danaher Schedules Fourth Quarter 2023 Earnings Conference CallDanaher Corporation (NYSE: DHR) announced that it will webcast its quarterly earnings conference call for the fourth quarter 2023 on Tuesday, January 30, 2024 beginning at 8:00 a.m. ET and lasting approximately one hour. During the call, the company will discuss its financial performance, as well as future expectations. |
Centi-Billionaire Bill Gates’ Top 15 Dividend StocksIn this article, we discuss centi-billionaire Bill Gates’ top 15 dividend stocks. You can skip our detailed analysis of Bill Gates’ investment philosophy and his major investments, and go directly to read Bill Gates’ Top 5 Dividend Stocks. Every investor dreams of accumulating higher returns and making massive profits while investing in the equity markets. […] |
Reasons to Retain Danaher (DHR) Stock in Your Portfolio NowStrength in the Life Sciences segment and accretive acquisition bode well for Danaher (DHR). The company's measures to reward its shareholders are encouraging. |
Danaher (DHR) Stock Falls Amid Market Uptick: What Investors Need to KnowDanaher (DHR) closed the most recent trading day at $226.45, moving -0.34% from the previous trading session. |
13 Most Profitable Pharmaceutical Stocks NowIn this article, we discuss the 13 most profitable pharmaceutical stocks to buy. You can skip our detailed analysis of the pharmaceutical sector and its outlook this year, and go directly to read the 5 Most Profitable Pharmaceutical Stocks Now. The healthcare sector encompasses a diverse range of companies, spanning pharmaceuticals, medical equipment and device […] |
2 Buys and 1 Sell From Al Gore's Investment CompanyAn industrial software company, a positioning and workflow company, and a leading life science, bioprocessing, and diagnostics company make up a list of stocks traded by Generation Investment Management. |
Codexis and Aldevron Enter Exclusive Licensing Agreement for Codex® HiCap RNA PolymeraseDeal creates strategic collaboration to enable more efficient RNA therapeutic development, providing a path to GMP-grade Codexis enzymesREDWOOD CITY, Calif. and FARGO, N.D., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading enzyme engineering company, today announced it has entered into an agreement with Aldevron, a global leader in the custom development and manufacture of plasmid DNA, RNA and proteins for the biotech industry, whereby Aldevron will acquire a global excl |
Danaher (DHR) Surpasses Market Returns: Some Facts Worth KnowingDanaher (DHR) concluded the recent trading session at $221.35, signifying a +1.77% move from its prior day's close. |